Top

01-01-2016 | Pancreatic cancer | Book chapter | Article

5. HIFU for Palliative Treatment of Pancreatic Cancer

Authors: Tatiana D. Khokhlova, Joo Ha Hwang

Publisher: Springer International Publishing

Abstract

Pancreatic cancer is one of the deadliest malignancies, with only a 6 % 5-year survival rate and over 50 % of patients being diagnosed at the advanced stage. Current therapies are ineffective, and the treatment of patients with advanced disease is palliative. In the past decade, HIFU ablation has emerged as a modality for palliative treatment of pancreatic tumors. Multiple preclinical and non-randomized clinical trials have been performed to evaluate the safety and efficacy of this procedure. Substantial tumor-related pain reduction was achieved in most cases after HIFU treatment and few significant side effects were observed. In addition, some studies indicate that combination of HIFU ablation with chemotherapy may provide a survival benefit. This chapter summarizes the pre-clinical and clinical experience obtained to date in HIFU treatment of pancreatic tumors and discusses the challenges, limitations and new approaches in this modality.

Anzidei M, Napoli A, Sandolo F, Marincola BC, Di Martino M, Berloco P, Bosco S, Bezzi M, Catalano C (2014) Magnetic resonance-guided focused ultrasound ablation in abdominal moving organs: a feasibility study in selected cases of pancreatic and liver cancer. Cardiovasc Intervent Radiol 37:1611–1617CrossRefPubMed

Arcidiacono PG, Calori G, Carrara S, McNicol ED and Testoni PA (2011) Celiac plexus block for pancreatic cancer pain in adults. Cochrane Database Syst Rev (3):CD007519

Balci NC, Semelka RC (2001) Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma. Eur J Radiol 38:105–112CrossRefPubMed

Bang S, Chung HW, Park SW, Chung JB, Yun M, Lee JD, Song SY (2006) The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer. J Clin Gastroenterol 40:923–929CrossRefPubMed

Bilimoria KY, Bentrem DJ, Ko CY, Ritchey J, Stewart AK, Winchester DP, Talamonti MS (2007) Validation of the 6th edition AJCC pancreatic cancer staging system: report from the National Cancer Database. Cancer 110:738–744CrossRefPubMed

Chen Q, Zhu X, Chen Q, Wang K, Meng Z (2013) Unresectable giant pancreatic neuroendocrine tumor effectively treated by high-intensity focused ultrasound: a case report and review of the literature. Pancreatology 13(6):634–638CrossRefPubMed

Chu GC, Kimmelman AC, Hezel AF, DePinho RA (2007) Stromal biology of pancreatic cancer. J Cell Biochem 101:887–907CrossRefPubMed

Damianou C, Pavlou M, Velev O, Kyriakou K, Trimikliniotis M (2004) High intensity focused ultrasound ablation of kidney guided by MRI. Ultrasound Med Biol 30:397–404CrossRefPubMed

Delaunoit T, Neczyporenko F, Rubin J, Erlichman C, Hobday TJ (2008) Medical management of pancreatic neuroendocrine tumors. Am J Gastroenterol 103:475–484CrossRefPubMed

Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2010) AJCC cancer staging manual, 7th edn. Springer, New York

Ge HY, Miao LY, Wang JR, Xiong LL, Yan F, Zheng CS, Jia JW, Cui LG, Chen W (2013) Correlation between ultrasound reflection intensity and tumor ablation ratio of late-stage pancreatic carcinoma in HIFU therapy: dynamic observation on ultrasound reflection intensity. Scientific World Journal 2013:852874PubMedCentralCrossRefPubMed

Ge HY, Miao LY, Xiong LL, Yan F, Zheng C, Wang JR, Jia JW, Cui LG, Chen W (2014) High-intensity focused ultrasound treatment of late-stage pancreatic body carcinoma: optimal tumor depth for safe ablation. Ultrasound Med Biol 40:947–955CrossRefPubMed

Haddock MG, Swaminathan R, Foster NR, Huage MD, Martenson JA, Camariano JK, Stella PJ, Tenglin RC, Schaefer PL, Moore DR Jr, Alberts SR (2007) Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: results of the North Central Cancer Treatment Group Phase II Study N9942. J Clin Oncol 25:2567–2572CrossRefPubMed

He SX and Wang GM (2002) The noninvasive treatment of 251 cases of advanced pancreatic cancer with focused ultrasound surgery. In: Proceedings of 2nd international symposium on therapeutic ultrasound, Seattle

Hellman P, Andersson M, Rastad J, Juhlin C, Karacagil S, Eriksson B, Skogseid B, Akerstrom G (2000) Surgical strategy for large or malignant endocrine pancreatic tumors. World J Surg 24:1353e60CrossRef

Hidalgo M (2010) Pancreatic cancer. N Engl J Med 362:1605–1617CrossRefPubMed

Hong SP, Park JY, Jeon TJ, Bang S, Park SW, Chung JB, Park MS, Seong J, Lee WJ, Song SY (2008) Weekly full-dose gemcitabine and single-dose cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer. Br J Cancer 98:881–887PubMedCentralCrossRefPubMed

Hwang JH, Wang YN, Warren C, Upton MP, Starr F, Zhou Y, Mitchell SB (2009) Preclinical in vivo evaluation of an extracorporeal HIFU device for ablation of pancreatic tumors. Ultrasound Med Biol 35:967–975CrossRefPubMed

Jang HJ, Lee JY, Lee DH, Kim WH, Hwang JH (2010) Current and future clinical applications of high-intensity focused ultrasound (HIFU) for pancreatic cancer. Gut Liver 1(Supp l):S57–S61CrossRef

Jiang L, Hu B, Guo Q, Chen L (2013) Treatment of pancreatic cancer in a nude mouse model using high-intensity focused ultrasound. Exp Ther Med 5:39–44PubMedCentralPubMed

Jolesz FA, Hynynen K, McDannold N, Tempany C (2005) MR imaging-controlled focused ultrasound ablation: a noninvasive image-guided surgery. Magn Reson Imaging Clin N Am 13:545–560CrossRefPubMed

Jung SE, Cho SH, Jang JH, Han JY (2011) High-intensity focused ultrasound ablation in hepatic and pancreatic cancer: complications. Abdom Imaging 36:185–195CrossRefPubMed

Karmazanovsky G, Fedorov V, Kubyshkin V, Kotchatkov A (2005) Pancreatic head cancer: accuracy of CT in determination of resectability. Abdom Imaging 30:488–500CrossRefPubMed

Khokhlova TD, Canney MS, Khokhlova VA, Sapozhnikov OA, Crum LA, Bailey MR (2011) Controlled tissue emulsification produced by high intensity focused ultrasound shock waves and millisecond boiling. J Acoust Soc Am 130:3498–3510PubMedCentralCrossRefPubMed

Lee JY, Choi BI, Ryu JK, Kim YT, Hwang JH, Kim SH, Han JK (2011) Concurrent chemotherapy and pulsed high-intensity focused ultrasound therapy for the treatment of unresectable pancreatic cancer: initial experiences. Korean J Radiol 12:176–186PubMedCentralCrossRefPubMed

Liu CX, Gao XS, Xiong LL, Ge HY, He XY, Li T, Zhang HJ, Bai HZ, Lin Q, Zhang M, Zhao J, Xiong W, Bai Y, Asaumi J (2011) A preclinical in vivo investigation of high-intensity focused ultrasound combined with radiotherapy. Ultrasound Med Biol 37:69–77CrossRefPubMed

Lu MD, Yu XL, Li AH, Jiang TA, Chen MH, Zhao BZ, Zhou XD, Wang JR (2007) Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China. Ultrasound Med Biol 33:1736–1749CrossRefPubMed

Mahadevan D, Von Hoff DD (2007) Tumor-stroma interactions in pancreatic ductal adenocarcinoma. Mol Cancer Ther 6:1186–1197CrossRefPubMed

Mao Y, Fang L, Ai L, Li C, Wang Z, Wu J, Bai J, Li F (2014) An in vivo study of the effects on serum glucose, amylase and histopathology of the feline pancreatic tissue treated by focused ultrasound. PLoS One 9(2), e88815PubMedCentralCrossRefPubMed

Mertz HR, Sechopoulos P, Delbeke D, Leach SD (2000) EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma. Gastrointest Endosc 52:367–371CrossRefPubMed

Miura F, Takada T, Amano H, Yoshida M, Furui S, Takeshita K (2006) Diagnosis of pancreatic cancer. HPB (Oxford) 8:337–342CrossRef

Orgera G, Krokidis M, Monfardini L, Bonomo G, Della Vigna P, Fazio N, Orsi F (2011) High intensity focused ultrasound ablation of pancreatic neuroendocrine tumours: report of two cases. Cardiovasc Intervent Radiol 34:419–423CrossRefPubMed

Orsi F, Zhang L, Arnone P, Orgera G, Bonomo G, Vigna PD, Monfardini L, Zhou K, Chen W, Wang Z, Veronesi U (2010) High intensity focused ultrasound (HIFU) ablation: effective and safe therapy for solid tumors at difficult locations. Am J Roentgenol 195:W245–W252CrossRef

Rykowski JJ, Hilgier M (2000) Efficacy of neurolytic celiac plexus block in varying locations of pancreatic cancer. Anesthesiology 92:347–354CrossRefPubMed

Shaib Y, Davila J, Naumann C, El-Serag H (2007) The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. population-based study. Am J Gastroenterol 102:1377–1382CrossRefPubMed

American Cancer Society (2013) Cancer Facts & Figures (2013) Available at http://www.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2013. Accessed 15 Aug 2014

Staatas PS, Hekmat H, Sauter P, Lillemoe K (2001) The effects of alcohol celiac block, pain, and mood on longevity in patients with unresectable pancreatic pain: a double blind, randomised, placebo-controlled study. Pain Med 2:28–34CrossRef

Sung HY, Jung SE, Cho SH, Zhou K, Han JY, Han ST, Kim JI, Kim JK, Choi JY, Yoon SK, Yang JM, Han CW, Lee YS (2011) Long-term outcome of high-intensity focused ultrasound in advanced pancreatic cancer. Pancreas 40:1080–1086CrossRefPubMed

Tucker ON, Crotty PL, Conlin KC (2006) The management of insulinoma. Br J Surg 93:264–275CrossRefPubMed

Wang K, Chen L, Meng Z, Lin J, Zhou Z, Wang P, Chen Z (2012) High intensity focused ultrasound treatment for patients with advanced pancreatic cancer: a preliminary dosimetric analysis. Int J Hyperthermia 28:645–652CrossRefPubMed

Wang K, Chen Z, Meng Z, Lin J, Zhou Z, Wang P, Chen L, Liu L (2011) Analgesic effect of high intensity focused ultrasound therapy for unresectable pancreatic cancer. Int J Hyperthermia 27:101–107CrossRefPubMed

Wang X, Sun JZ (2002) Preliminary study of high intensity focused ultrasound in treating patients with advanced pancreatic carcinoma. Chin J Gen Surg 17:654–655

Wu F, Wang ZB, Chen WZ, Zou JZ, Bai J, Zhu H, Li KQ, Xie FL, Jin CB, Su HB, Gao GW (2004) Extracorporeal focused ultrasound surgery for treatment of human solid carcinomas: early Chinese clinical experience. Ultrasound Med Biol 30:245–260CrossRefPubMed

Wu F, Wang ZB, Zhu H, Chen WZ, Zou JZ, Bai J, Li KQ, Jin CB, Xie FL, Su HB (2005) Feasibility of US-guided high-intensity focused ultrasound treatment in patients with advanced pancreatic cancer: initial experience. Radiology 236:1034–1040CrossRefPubMed

Xie B, Li YY, Jia L, Nie YQ, Du H, Jiang SM (2010) Experimental ablation of the pancreas with high intensity focused ultrasound (HIFU) in a porcine model. Int J Med Sci 8:9–15PubMedCentralPubMed

Xie DR, Chen D, Teng H (2003) A multicenter non-randomized clinical study of high intensity focused ultrasound in treating patients with local advanced pancreatic carcinoma. Chin J Clin Oncol 30:630–634

Xiong LL, He CJ, Yao SS, Zeng JQ, Zhang GX, Huang K, He SX (2005) The preliminary clinical results of the treatment for advanced pancreatic carcinoma by high intensity focused ultrasound. Chin J Gen Surg 16:345–347

Xiong LL, Hwang JH, Huang XB, Yao SS, He CJ, Ge XH, Ge HY, Wang XF (2009) Early clinical experience using high intensity focused ultrasound for palliation of inoperable pancreatic cancer. JOP 10:123–129PubMed

Xu YQ, Wang GM, Gu YZ, Zhang HF (2003) The acesodyne effect of high intensity focused ultrasound on the treatment of advanced pancreatic carcinoma. Clin Med J China 10:322–323

Yuan C, Yang L, Yao C (2003) Observation of high intensity focused ultrasound treating 40 cases of pancreatic cancer. Chin J Clin Hep 19:145

Zhao H, Yang G, Wang D, Yu X, Zhang Y, Zhu J, Ji Y, Zhong B, Zhao W, Yang Z, Aziz F (2010) Concurrent gemcitabine and high-intensity focused ultrasound therapy in patients with locally advanced pancreatic cancer. Anticancer Drugs 21:447–452CrossRefPubMed

Medicine Matters Oncology

Abstract